Skip to content

Independent Walking for Brain Health

A Novel Mobile Health Exercise Intervention in Aging: Brain Perfusion and Cognition

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03058146
Enrollment
53
Registered
2017-02-20
Start date
2017-10-12
Completion date
2020-05-20
Last updated
2023-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Physical Activity

Keywords

Exercise, Fitness, Physical Activity, Cognitive Aging, Cerebral Blood Flow, Brain Imaging, Unsupervised Intervention, Mobile Health, Free-living exercise intervention

Brief summary

Physical activity interventions with older adults can improve brain health; however most interventions have been performed in gym-like settings that reach a small sector of the senior population. Since not everyone can access a gym, it is important to study whether brisk walking in real world environments can also help brain health. This study will use mobile health devices to help older adults independently walk for brain health, thus representing a critical step towards the dissemination of physical activity intervention programs aimed at preserving cognitive function in aging.

Detailed description

Physical activity interventions conducted in supervised settings (laboratories and group settings) with older adults have consistently shown improved cardiovascular and cerebrovascular health and improved cognitive function. What is lacking is the development of interventions that take place in real world environments and that take advantage of new technologies to help objectively track real time physical activity behaviors. Real world physical activity interventions have the potential to reach a larger segment of the population and to enhance maintenance after the intervention period ends. This study will develop a novel physical activity intervention using mobile health technologies to promote physical activity levels likely to affect cerebral blood flow and cognition in real world environments in cognitively normal older adults. A randomized controlled trial will be conducted with 30 participants being assigned to the mobile health physical activity condition (walking in free-living environments tracked via mobile health technologies) and another 30 to an education control condition (at home reading about healthy aging materials) for 3 months.

Interventions

BEHAVIORALMobile Health Walking Condition

Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.

BEHAVIORALHealthy Aging Education Condition

The education control condition will provide participants with printed materials and homework assignments on issues related to successful aging, such as nutrition, social activity, cognitive and social engagement.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Aging (NIA)
CollaboratorNIH
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Trial with ongoing enrollment into each arm (individual intervention)

Eligibility

Sex/Gender
ALL
Age
65 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women between the ages of 65-80 * Ability to obtain a signed physician's clearance for participation in this study * English-speaking as needed to complete cognitive testing and follow study procedures * Cognitively normal (based on comprehensive neuropsychological assessment) * No contraindications for Magnetic Resonance Imaging (MRI) * Must be ambulatory and able to walk independently

Exclusion criteria

* History of head injury involving loss of consciousness within the past 6 months and/or history of severe traumatic brain injury * Major neurological disorders (dementia, multiple sclerosis, epilepsy, etc) * Chronic major psychiatric disorders (schizophrenia, major recurrent affective disorder) * History of major vascular events (myocardial infarction, stroke, etc), * History of diabetes * History of falls in the last year resulting in hospitalization * Unstable or poorly controlled medical problems e.g. heart failure, diabetes (poorly controlled or on insulin), uncontrolled hypertension, pulmonary disease with hypoxia or hypercapnia, significant liver problems or renal failure, treatment of cancer in the past 2 years (other than non-melanoma skin cancer), HIV positive * Objective evidence of cognitive impairment based on neuropsychological assessment

Design outcomes

Primary

MeasureTime frameDescription
Moderate to Vigorous Physical Activity (MVPA) Average Per DayPre (baseline) and post (3 months)Average minutes per day spent in moderate to vigorous levels of physical activity (MVPA) (defined as =\>1952 accelerometer counts per minute). MVPA minutes were determined based on one-week of accelerometer wear on the hip at baseline and post intervention.

Secondary

MeasureTime frameDescription
Cerebral Blood Flow (Hippocampal and Frontal)Pre (baseline) and post (3 months)Average cerebral blood flow measured with arterial spin labeling magnetic resonance imaging in ml/100g/min. Cerebral blood flow was obtained via arterial spin labeling MRI and Freesurfer software was utilized to delineate regions of interest for each participant (right and left regions were averaged). For the frontal lobe cerebral blood flow we averaged the mean of superior frontal, rostral and caudal middle frontal, pars opercularis, pars triangularis, pars orbitalis, lateral and medial orbitofrontal, precentral, paracentral, and frontal pole.

Other

MeasureTime frameDescription
Memory FunctionPre (baseline) and post (3 months)A memory composite score was created by converting raw scores into z-scores and then averaging them for the following tests: Rey Auditory Verbal Learning Test trials 1 to 5, trial 6 (short-delay free recall), and delayed recall; Wechsler Memory Scale - Revised Logical Memory I and II (immediate and delayed recall scores). Z-scores were calculated using raw scores for these tests in the entire sample \[(raw score-mean of the sample)/standard deviation of the sample\]. Z-scores of 0 represent the sample's mean performance on the tests, z-scores \>0 indicate better performance compared to the sample's mean, while z-scores \<0 indicate worse performance compared to the sample's mean.
Executive FunctionPre (baseline) and post (3 months)An executive function composite score was created by converting raw scores into z-scores and then averaging them for the following tests: Trail Making Test Part B minus Trail Making Test Part A, Golden version of the Stroop Color Word Trial, and verbal fluency (letters F,A,S). Trail making test scores were reversed prior to averaging, so higher scores = better performance. Z-scores were calculated using raw scores for these tests in the entire sample \[(raw score-mean of the sample)/standard deviation of the sample\]. Z-scores of 0 represent the sample's mean performance on the tests, z-scores \>0 indicate better performance compared to the sample's mean, while z-scores \<0 indicate worse performance compared to the sample's mean.
Cardiorespiratory FitnessPre (baseline) and post (3 months)Total time it takes the participant to reach 85% of their estimated maximal heart rate (220-age) measured via sub-maximal treadmill test in seconds.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from ongoing studies at the University of California San Diego and the Shiley-Marcos Alzheimer's Disease Research Center, as well as from ResearchMatch, flyers, community engagement talks (ie, talks at retirement communities, senior centers, libraries, and health fairs) and by word of mouth. All participants were enrolled between October 2017 and March 2020, at which time study recruitment was terminated because of the COVID-19 pandemic.

Pre-assignment details

53 participants were enrolled (signed informed consent). After enrollment, 7 did not meet further eligibility criteria (based on cognitive and fitness testing) and 2 did not complete the baseline sessions due to the COVID-19 shut down. Out of 53 enrolled, 44 were randomized to the exercise (n=21) and control conditions (n=23). One participant randomized to the control condition could not start the intervention due to the COVID-19 shut down. Total analytic sample is N=43 (exercise=21,control=22).

Participants by arm

ArmCount
Physical Activity Condition
Physically inactive older adults in this condition will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
21
Healthy Aging Education Condition
The education control condition will provide participants with materials and homework assignments on issues related to successful aging, such as nutrition, healthcare, and the typical changes associated with aging.
22
Total43

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyCoronavirus (COVID)-19 shutdown01
Overall StudyWithdrawal by Subject41

Baseline characteristics

CharacteristicPhysical Activity ConditionHealthy Aging Education ConditionTotal
Age, Continuous71.24 years
STANDARD_DEVIATION 4.27
72.27 years
STANDARD_DEVIATION 4.14
71.77 years
STANDARD_DEVIATION 4.19
Baseline MVPA26.37 Average MVPA minutes per day
STANDARD_DEVIATION 17.31
21.32 Average MVPA minutes per day
STANDARD_DEVIATION 17.42
23.8 Average MVPA minutes per day
STANDARD_DEVIATION 17.36
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants1 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants21 Participants37 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants0 Participants3 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
18 Participants22 Participants40 Participants
Region of Enrollment
United States
21 participants22 participants43 participants
Sex: Female, Male
Female
16 Participants16 Participants32 Participants
Sex: Female, Male
Male
5 Participants6 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 210 / 22
other
Total, other adverse events
3 / 212 / 22
serious
Total, serious adverse events
0 / 210 / 22

Outcome results

Primary

Moderate to Vigorous Physical Activity (MVPA) Average Per Day

Average minutes per day spent in moderate to vigorous levels of physical activity (MVPA) (defined as =\>1952 accelerometer counts per minute). MVPA minutes were determined based on one-week of accelerometer wear on the hip at baseline and post intervention.

Time frame: Pre (baseline) and post (3 months)

Population: All participants who were randomized and completed the baseline sessions were included in the analyses (N=43).

ArmMeasureGroupValue (MEAN)Dispersion
Physical Activity ConditionModerate to Vigorous Physical Activity (MVPA) Average Per DayPre MVPA average minutes per day26.37 average minutes per dayStandard Deviation 17.31
Physical Activity ConditionModerate to Vigorous Physical Activity (MVPA) Average Per DayPost MVPA average minutes per day44.09 average minutes per dayStandard Deviation 25.28
Healthy Aging Education ConditionModerate to Vigorous Physical Activity (MVPA) Average Per DayPre MVPA average minutes per day21.34 average minutes per dayStandard Deviation 17.44
Healthy Aging Education ConditionModerate to Vigorous Physical Activity (MVPA) Average Per DayPost MVPA average minutes per day25.28 average minutes per dayStandard Deviation 15.99
Secondary

Cerebral Blood Flow (Hippocampal and Frontal)

Average cerebral blood flow measured with arterial spin labeling magnetic resonance imaging in ml/100g/min. Cerebral blood flow was obtained via arterial spin labeling MRI and Freesurfer software was utilized to delineate regions of interest for each participant (right and left regions were averaged). For the frontal lobe cerebral blood flow we averaged the mean of superior frontal, rostral and caudal middle frontal, pars opercularis, pars triangularis, pars orbitalis, lateral and medial orbitofrontal, precentral, paracentral, and frontal pole.

Time frame: Pre (baseline) and post (3 months)

Population: We provide descriptive statistics for pre and post cerebral blood flow in the hippocampus and frontal cortex.

ArmMeasureGroupValue (MEAN)Dispersion
Physical Activity ConditionCerebral Blood Flow (Hippocampal and Frontal)Pre hippocampal cerebral blood flow40.4 ml/100g/minuteStandard Deviation 10.82
Physical Activity ConditionCerebral Blood Flow (Hippocampal and Frontal)Post hippocampal cerebral blood flow35.36 ml/100g/minuteStandard Deviation 5.56
Physical Activity ConditionCerebral Blood Flow (Hippocampal and Frontal)Pre frontal cerebral blood flow45.52 ml/100g/minuteStandard Deviation 11.58
Physical Activity ConditionCerebral Blood Flow (Hippocampal and Frontal)Post frontal cerebral blood flow41.31 ml/100g/minuteStandard Deviation 7.41
Healthy Aging Education ConditionCerebral Blood Flow (Hippocampal and Frontal)Post frontal cerebral blood flow46.96 ml/100g/minuteStandard Deviation 10.7
Healthy Aging Education ConditionCerebral Blood Flow (Hippocampal and Frontal)Pre hippocampal cerebral blood flow41.03 ml/100g/minuteStandard Deviation 12.24
Healthy Aging Education ConditionCerebral Blood Flow (Hippocampal and Frontal)Pre frontal cerebral blood flow47.24 ml/100g/minuteStandard Deviation 10.46
Healthy Aging Education ConditionCerebral Blood Flow (Hippocampal and Frontal)Post hippocampal cerebral blood flow40.99 ml/100g/minuteStandard Deviation 9.1
Other Pre-specified

Cardiorespiratory Fitness

Total time it takes the participant to reach 85% of their estimated maximal heart rate (220-age) measured via sub-maximal treadmill test in seconds.

Time frame: Pre (baseline) and post (3 months)

Population: Descriptive data are presented for pre and post.

ArmMeasureGroupValue (MEAN)Dispersion
Physical Activity ConditionCardiorespiratory FitnessPre cardiorespiratory fitness (seconds)873.48 secondsStandard Deviation 175.47
Physical Activity ConditionCardiorespiratory FitnessPost cardiorespiratory fitness (seconds)995.71 secondsStandard Deviation 157.43
Healthy Aging Education ConditionCardiorespiratory FitnessPre cardiorespiratory fitness (seconds)840.55 secondsStandard Deviation 277.62
Healthy Aging Education ConditionCardiorespiratory FitnessPost cardiorespiratory fitness (seconds)948.61 secondsStandard Deviation 172.52
Other Pre-specified

Executive Function

An executive function composite score was created by converting raw scores into z-scores and then averaging them for the following tests: Trail Making Test Part B minus Trail Making Test Part A, Golden version of the Stroop Color Word Trial, and verbal fluency (letters F,A,S). Trail making test scores were reversed prior to averaging, so higher scores = better performance. Z-scores were calculated using raw scores for these tests in the entire sample \[(raw score-mean of the sample)/standard deviation of the sample\]. Z-scores of 0 represent the sample's mean performance on the tests, z-scores \>0 indicate better performance compared to the sample's mean, while z-scores \<0 indicate worse performance compared to the sample's mean.

Time frame: Pre (baseline) and post (3 months)

Population: All participants were included and descriptive statistics are presented for pre and post.

ArmMeasureGroupValue (MEAN)Dispersion
Physical Activity ConditionExecutive FunctionPre executive function score.15 z-scoreStandard Deviation 0.69
Physical Activity ConditionExecutive FunctionPost executive function score.07 z-scoreStandard Deviation 0.73
Healthy Aging Education ConditionExecutive FunctionPre executive function score-.14 z-scoreStandard Deviation 0.8
Healthy Aging Education ConditionExecutive FunctionPost executive function score-.06 z-scoreStandard Deviation 0.84
Other Pre-specified

Memory Function

A memory composite score was created by converting raw scores into z-scores and then averaging them for the following tests: Rey Auditory Verbal Learning Test trials 1 to 5, trial 6 (short-delay free recall), and delayed recall; Wechsler Memory Scale - Revised Logical Memory I and II (immediate and delayed recall scores). Z-scores were calculated using raw scores for these tests in the entire sample \[(raw score-mean of the sample)/standard deviation of the sample\]. Z-scores of 0 represent the sample's mean performance on the tests, z-scores \>0 indicate better performance compared to the sample's mean, while z-scores \<0 indicate worse performance compared to the sample's mean.

Time frame: Pre (baseline) and post (3 months)

Population: All participants completed neuropsychological testing at pre and post.

ArmMeasureGroupValue (MEAN)Dispersion
Physical Activity ConditionMemory FunctionPre memory score.08 z-scoreStandard Deviation 0.8
Physical Activity ConditionMemory FunctionPost memory score-.10 z-scoreStandard Deviation 0.94
Healthy Aging Education ConditionMemory FunctionPre memory score-.07 z-scoreStandard Deviation 0.82
Healthy Aging Education ConditionMemory FunctionPost memory score.09 z-scoreStandard Deviation 0.68

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026